LMR Partners LLP Acquires Shares of 141,785 Aspen Aerogels, Inc. (NYSE:ASPN)

LMR Partners LLP bought a new position in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 141,785 shares of the construction company's stock, valued at approximately $1,684,000. LMR Partners LLP owned about 0.17% of Aspen Aerogels at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in ASPN. AlphaQuest LLC lifted its holdings in Aspen Aerogels by 54.0% during the 4th quarter. AlphaQuest LLC now owns 11,395 shares of the construction company's stock valued at $135,000 after buying an additional 3,998 shares in the last quarter. KLP Kapitalforvaltning AS bought a new stake in Aspen Aerogels during the 4th quarter valued at about $164,000. Connors Investor Services Inc. bought a new stake in Aspen Aerogels during the 4th quarter valued at about $168,000. Journey Strategic Wealth LLC bought a new stake in Aspen Aerogels during the 4th quarter valued at about $178,000. Finally, Ballentine Partners LLC lifted its holdings in Aspen Aerogels by 19.2% during the 4th quarter. Ballentine Partners LLC now owns 15,914 shares of the construction company's stock valued at $189,000 after buying an additional 2,565 shares in the last quarter. Institutional investors own 97.64% of the company's stock.

Aspen Aerogels Stock Up 12.0%

Shares of Aspen Aerogels stock traded up $0.69 on Friday, reaching $6.38. The stock had a trading volume of 2,882,826 shares, compared to its average volume of 1,960,784. The company has a 50 day moving average price of $5.89 and a 200 day moving average price of $10.13. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. Aspen Aerogels, Inc. has a 1 year low of $4.16 and a 1 year high of $33.15. The stock has a market capitalization of $523.42 million, a P/E ratio of 39.85 and a beta of 2.72.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The construction company reported ($0.06) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.07) by $0.01. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. The firm had revenue of $78.72 million for the quarter, compared to the consensus estimate of $82.75 million. During the same quarter in the previous year, the firm earned ($0.02) EPS. The company's quarterly revenue was down 16.7% compared to the same quarter last year. As a group, equities research analysts forecast that Aspen Aerogels, Inc. will post 0.17 EPS for the current year.

Insiders Place Their Bets

In related news, CEO Donald R. Young bought 20,000 shares of the company's stock in a transaction on Monday, May 12th. The shares were bought at an average price of $5.35 per share, with a total value of $107,000.00. Following the transaction, the chief executive officer now owns 550,856 shares in the company, valued at approximately $2,947,079.60. This trade represents a 3.77% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 4.30% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

ASPN has been the topic of a number of research reports. Canaccord Genuity Group cut their target price on shares of Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating on the stock in a research report on Friday, February 14th. StockNews.com raised shares of Aspen Aerogels to a "sell" rating in a research report on Wednesday, February 19th. Roth Mkm cut their target price on shares of Aspen Aerogels from $22.00 to $16.00 and set a "buy" rating on the stock in a research report on Friday, February 14th. TD Cowen raised shares of Aspen Aerogels to a "strong-buy" rating in a research report on Tuesday, March 11th. Finally, Oppenheimer downgraded shares of Aspen Aerogels from an "outperform" rating to a "market perform" rating in a research report on Thursday, May 8th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $19.11.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.